Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/06/2010CN101849914A Slow-release solid preparation taking carvedilol as main component and preparation method thereof
10/06/2010CN101849913A Method for preparing veterinary florfenicol lung targeting gelatin microsphere
10/06/2010CN101849912A Cefepime hydrochloride composition sterile powder for injection
10/06/2010CN101849911A Improvements relating to antiparasitcs
10/06/2010CN101849910A Preparation method of betamethasone dipropionate micro-particle
10/06/2010CN101849909A Preparation method of magnetic disodium clodronate liposome
10/06/2010CN101849908A Oral fungi polysaccharide sulfate pro-liposome and preparation method thereof
10/06/2010CN101849907A Nanoemulsion of N-[4-(2,4 dimethoxy phenyl)-5-oxygroup-4,5-dihydro-[1,2] disulfide group-[4,3-b]-6-pyrryl]-3,5-di-trifluoromethyl benzamide and preparation method thereof
10/06/2010CN101849906A Methods for the treatment of endometriosis
10/06/2010CN101849905A Voriconazole eye drops and preparation method thereof
10/06/2010CN101849904A Palonosetron injection and preparation method thereof
10/06/2010CN101849903A Suppository for alleviating pain
10/06/2010CN101849902A Preparation method of solid pharmaceutical composition containing desloratadine
10/06/2010CN101849675A Dietary supplements containing natural ingredients
10/06/2010CN101849526A Qi-deficiency fever animal model and preparation method and application thereof
10/06/2010CN101530392B Omeprazole sodium freeze-dried lipidosome preparation
10/06/2010CN101417130B Medicine combination for treating II type diabetes and complicating diseases thereof
10/06/2010CN101391104B New use of oncolytic adenovirus recombinant of tumour cell single-expression immunoloregulation fator GM-CSF
10/06/2010CN101361907B Hypoglycemic, antihypertensive formulation and preparation technique thereof
10/06/2010CN101352434B Use of triptolide in preparing medicament for treating c-KIT tyrosine kinase related tumor
10/06/2010CN101336901B Anti-coccidium microemulsion containing toltrazuril and preparation method thereof
10/06/2010CN101334356B Gas sensors
10/06/2010CN101310748B Ointment for treating empyrosis
10/06/2010CN101301354B Externally used medicinal liquor for treating psoriasis
10/06/2010CN101297862B Capsule for treating rhinitis
10/06/2010CN101293065B Biological proprietary Chinese medicine for preventing and treating diabetes
10/06/2010CN101279089B Donkey-hide gelatin calcium composition and preparing process thereof
10/06/2010CN101279048B Chinese medicine for curing cold mainly and preparation thereof
10/06/2010CN101264194B Chinese medicinal composition for treating traumatism
10/06/2010CN101264099B Medicaments for treating acne rosacea, comedo and acne
10/06/2010CN101220359B SiRNA sequence restraining bak gene expression
10/06/2010CN101181224B Solid dispersion of entecavir, pharmaceutical composition and preparation method as well as uses thereof
10/06/2010CN101177433B (s)-ornidazole disodium phosphate pentahydrate as well as preparation method and uses thereof
10/06/2010CN101168009B Quality control method of macaque stone bovinebezoar powder
10/06/2010CN101156835B Preparation method of hypericin oral liquid
10/06/2010CN101152205B Inosine injection and method of preparing the same
10/06/2010CN101152178B Sophoridine nano liposome medicament and preparation of the same
10/06/2010CN101147743B Application of ginsenoside Compound-K in pharmaceutical
10/06/2010CN101138541B Amlexanox partial film forming gel composition and uses thereof
10/06/2010CN101130561B Method for producing salidroside and injection containing the same
10/06/2010CN101129362B Sirolimus dispersible tablets and method of producing the same
10/06/2010CN101120915B Dexamethasone sodium phosphate injection
10/06/2010CN101120758B Liquid acidifier and preparation method
10/06/2010CN101113163B Hla-a24-restricted cancer antigen peptides
10/06/2010CN101112509B Oral administration Chinese traditional medicine composition for treating chronic sinusitis
10/06/2010CN101108172B Oral sticking tablet and method of preparing the same
10/06/2010CN101095670B Luteolin phospholipid complexes and method for preparing the same and application thereof
10/06/2010CN101095667B Liquid for disinfecting wound
10/06/2010CN101095666B Novel hydrochloric acid tramadol sustained-release tablet and preparation method
10/06/2010CN101081213B Butane diacid(5-androstene-17-ketone- 3beta -hydroxyl group ) diester solid dispersoid and method for making same and applications thereof
10/06/2010CN101073563B Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet
10/06/2010CN101058823B Method of preparing cytidine disodium triphosphate and application
10/06/2010CN101040911B Chinese traditional medicine capsule preparation for treating and preventing diabetes and the method of preparing the same
10/06/2010CN101040905B Medicine made by selfheal for reducing blood sugar
10/06/2010CN101028284B Externally-applied zeolite hemostat and its preparation
10/06/2010CN101011393B Irbesartan gastric retention sustained-release pharmaceutical composition
10/05/2010US7809428 Devices for detection and therapy of atheromatous plaque
10/05/2010US7809417 Contact lens for collecting tears and detecting analytes for determining health status, ovulation detection, and diabetes screening
10/05/2010US7807845 Enzyme inhibitor for treating HIV infections; viricides; patient is suffering from a multi-drug resistant HIV infection; AIDS therapy; {1-Benzyl-3-[(3-dimethylaminomethylene-2-oxo-2,3-dihydro-1H-indole-5-sulfonyl)-isobutyl-amino]-2-hydroxy-propyl}-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester
10/05/2010US7807842 Synthesis of tetracyclines and analogues thereof
10/05/2010US7807825 superoxide dismutase mimetics such as manganese(III) 5,10,15,20-tetrakis[N,N'-diethylimidazolium-2-yl]porphyrin, used for the treatment for oxidative stress injuries, including asthma, neurodegenerative disease, cancer, diabetes, cardiovascular disorders, sickle cell anemia and radiation injury
10/05/2010US7807824 in which reducing terminal unit is transformed into aldehyde group, hydroxylation; drug delivery
10/05/2010US7807822 Purification of plasmid nucleotide sequences from bacterial cells; obtain cells, lyse, precipatate, centrifuge precipitate mixture, expose to ion exchange column, recover nucleotide sequences
10/05/2010US7807817 Catalytic DNA molecule having site-specific endonuclease activity which cleaves RNA in site specific manner; enzyme engineering technology and directed protein evolution
10/05/2010US7807809 Molecular characterization of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis
10/05/2010US7807803 For prophylaxis and therapy of infectious disease, allergy, cancer
10/05/2010US7807801 Method of inhibition of flavivirus to prevent and cure viral diseases by administering nucleotides
10/05/2010US7807795 Antibodies to osteoprotegerin binding proteins
10/05/2010US7807787 NELL-1 (Nel-like molecule-1) polypeptide for use in induction and treatment of bone formation and disorders
10/05/2010US7807721 3-methyl-1-alkyn-3-ols or 3-methyl-1-alkene-3-ols, such as nerolidol, 3-methyl-1-octen-3-ol, linalool and dehydrolinalool, used for for inhibiting the ability of mosquitoes to locate a target by olfactory emissions of the target
10/05/2010US7807720 Hydroxamic acid derivatives of 3-phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning
10/05/2010US7807719 4-Chloro-2-cyano-5-phenyl-penta-2E,4Z-dienoic acid 3,4-dihydroxybenzylamide, used as antiproliferative agents
10/05/2010US7807716 Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
10/05/2010US7807715 Pharmaceutical compositions comprising fesoterodine
10/05/2010US7807713 treatment of androgen-dependent disorders selected from prostate cancer, acne, seborrhea, hirsutism, alopecia and hidradenitis suppurativa comprising administering androgen receptor antagonists such as N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-3-(naphthalen-1-ylsulfonyl)propanamide
10/05/2010US7807712 Oxy substituted chalcones as antihyperglycemic and antidyslipidemic agents
10/05/2010US7807711 administering plant extracts including tetrahydrocannabinolic acid and tetrahydrocannabinol, as analgesics and/or antiinflammatory agents
10/05/2010US7807710 epothilone-like derivates used as anticarcinotgenic and antitumor agents
10/05/2010US7807709 3,4-substituted pyrrolidines; renin inhibitors; cardiovascular disorders, kidney disorders, neurodegenerative diorders and other diseases related to renin; e.g. N-((3S*,4S*)-4-{[Cyclopropyl-(4-methyl-pentanoyl)-amino]-methyl}-pyrrolidin-3-ylmethyl)-N-isopropyl-4-methoxy-3-(3-methoxy-propoxy)-benzamide
10/05/2010US7807708 retinoic acid receptor modulators such as ethyl 3''-tert-butyl-4''-diethylamino-4'-hydroxy[1,1';3',1'']terphenyl-4-carboxylate, used for for preventing and/or treating the signs of aging and/or dry sun
10/05/2010US7807706 5-bromo-2-[4-(2-fluorophenoxy)benzyl]-7-methyl-2,3-dihydro-isoindol-1-one; central nervous system, neural plasticity, neural development and neurodegeneration
10/05/2010US7807705 [1-(3'-nitro-4'-chlorobenzenesulfonyl)-1H-indol-3-yl]-methanol, used for inducing apoptosis in unwanted rapidly proliferating cells, treating, inhibiting or delaying the onset of cancer
10/05/2010US7807704 chemokine receptor modulators such as N-[2-(Cyclohexyl-methyl-amino)-ethyl]-2-[7-(4-trifluoromethyl-phenyl)-indol-1-yl]-acetamide, used for preventing tumor cell proliferation, tumor formation, metastasis, inflammatory diseases, treatment of HIV infections and vision defects
10/05/2010US7807702 Substituted thiophene carboxylic amide glucagon receptor antagonists, preparation and therapeutic uses
10/05/2010US7807701 Dibenzylamine compounds and pharmaceutical use thereof
10/05/2010US7807700 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/05/2010US7807698 Such as (1S,5R)-3-{3-[(5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)thio]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; for use as modulators of dopamine D3 receptors, antipsychotic agents, treatment of obsessive compulsive spectrum disorders and/or premature ejaculation
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010US7807696 Isoxazole and isothiazole compounds useful in the treatment of inflammation
10/05/2010US7807695 Treating skin wrinkles, especially expression wrinkles such as crow's feet; muscle relaxants; 6-{2-[4-(3-phenylpropyl)-piperidin-1-yl]ethyl}undecan-6-ol for example
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807693 e.g. 4-methoxy-pyrrolidine-1,2-dicarboxylic acid-1-[(4-chloro-phenyl)-amide]-2-(2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-yl)-amide; factor Xa and related serine proteases inhibitor; anticoagulant, thrombolytic agent
10/05/2010US7807692 peroxisome proliferator activated receptor agonists useful in the treatment and control of hyperglycemia that is symptomatic of non-insulin dependent diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia and obesity that are often associated with type II diabetes
10/05/2010US7807691 [4-(3-Methoxy-phenyl)-4-oxo-butyl]-carbamic acid tert-butyl ester; Age related functional decline, osteoporosis, osteopenia, bone fractures, male and female sexual dysfunction, erectile dysfunction, depression, prostate cancer, decreased cognitive ability, or lethargy
10/05/2010US7807690 such as 2-(3-aminopyridin-2-yl)-5-[(1-imino-2,3-dihydro-1H-isoindol-5-ylamino)-(8-methoxy-4H-benzo[1,3]dioxin-6-yl)methyl]-2,4-dihydro-1,2,4-triazol-3-one, having serine protease inhibiting activity, and particularly excellent inhibiting activity against blood-coagulation factor VIIa
10/05/2010US7807689 such as 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile, used for the treatment of breast cancer and non-insulin depepndent diabetes
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807687 Reaction of a 2,4-disubstituted quinolinone with an aldehyde in the presence of a base to prepare a benzylidene hydroquinolinone, reaction of product with benzamidinium hydrochloride under basic conditions to prepare a 1,4,5,6-tetrahydropyrido[3,2-h]quinazoline, oxidation; performance efficiency; OLED
10/05/2010US7807686 2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists
10/05/2010US7807685 Therapeutic compounds
1 ... 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 ... 7860